STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Sees Significant Increase in Short Interest

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) was the target of a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 5,500 shares, a growth of 48.6% from the October 15th total of 3,700 shares. Based on an average daily trading volume, of 12,500 shares, the short-interest ratio is currently 0.4 days. Currently, 0.2% of the shares of the company are sold short.

Hedge Funds Weigh In On STRATA Skin Sciences

An institutional investor recently bought a new position in STRATA Skin Sciences stock. Azzad Asset Management Inc. ADV bought a new stake in STRATA Skin Sciences, Inc. (NASDAQ:SSKN) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 12,000 shares of the medical device company’s stock, valued at approximately $33,000. Azzad Asset Management Inc. ADV owned approximately 0.34% of STRATA Skin Sciences as of its most recent SEC filing. Hedge funds and other institutional investors own 32.43% of the company’s stock.

STRATA Skin Sciences Stock Performance

Shares of NASDAQ:SSKN traded down $0.09 during trading on Friday, reaching $3.01. 5,058 shares of the company’s stock traded hands, compared to its average volume of 12,246. The company has a debt-to-equity ratio of 1.59, a current ratio of 1.14 and a quick ratio of 0.92. The company has a 50 day moving average of $3.01 and a 200-day moving average of $3.23. STRATA Skin Sciences has a 12 month low of $2.51 and a 12 month high of $6.96. The stock has a market capitalization of $12.55 million, a P/E ratio of -1.13 and a beta of 1.32.

STRATA Skin Sciences (NASDAQ:SSKN) last announced its quarterly earnings results on Wednesday, August 14th. The medical device company reported ($0.03) earnings per share (EPS) for the quarter. The company had revenue of $8.44 million during the quarter. STRATA Skin Sciences had a negative return on equity of 67.36% and a negative net margin of 28.72%. On average, equities analysts expect that STRATA Skin Sciences will post -1 EPS for the current year.

About STRATA Skin Sciences

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.